RECOVERY ROOM EARLY WARNING SCORE
Not yet recruiting
- Conditions
- Early Warning Score
- Registration Number
- NCT07051421
- Lead Sponsor
- Istinye University
- Brief Summary
In this study, we aimed to develop a scoring system that facilitates patient risk stratification in the recovery room during the postanesthetic follow-up period and can objectively identify patients in need of early intervention.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 208
Inclusion Criteria
- Those over 18 years of age,
- Those in ASA I-III class,
- Those who have undergone planned elective surgery under general anesthesia,
- Those who have been informed about the study in advance and given their consent.
Exclusion Criteria
- Those under 18 years of age,
- Those who underwent emergency intervention,
- Those in the ASA-Ⅳ class,
- Those who underwent regional anesthesia,
- Those with a history of cognitive retardation, visual-hearing impairment or psychiatric disease that prevents communication, those who have previously been diagnosed with neurocognitive disorders,
- Patients who could not complete the procedure, patients with data loss,
- Patients whose general anesthesia duration is less than 90 minutes will not be included in the study.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method RECO-EWS 24 HOURS 0-7 low risk, 7-10 medium risk, ≥10 high risk
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the RECO-EWS score's ability to predict postanesthetic complications?
How does the RECO-EWS compare to traditional early warning scores like MEWS or qSOFA in recovery room settings?
Are there specific biomarkers associated with high-risk postanesthetic patients that RECO-EWS incorporates?
What adverse events are commonly observed in postanesthetic recovery rooms and how does RECO-EWS aid in their early detection?
What are the potential implications of RECO-EWS implementation on postoperative patient management and outcomes?